TCP
ELDN icon

Tourbillon Capital Partners’s Eledon Pharmaceuticals ELDN Stock Holding History

Tourbillon Capital Partners’s Portfolio ELDN Stock Details ELDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-3,191
Closed -$6.88M – 111
2015
Q2 		$6.88M Hold
3,191
– – 0.24% 89
2015
Q1 		$5.84M Hold
3,191
– – 0.23% 66
2014
Q4 		$7.62M Buy
3,191
+228
+8% +$541K 0.42% 78
2014
Q3 		$7.27M Buy
+2,963
New +$8.42M 0.61% 67

Other funds holding ELDN

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
KCM
Kingdon Capital Management New York $597M AUM 51.11% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $5.71M AUM 74.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return